Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density

Journal article

Peer reviewed

J. A. Eisman, Robert R. Recker, M. McClung, H. Bone, C. Roux, N. Verbruggen, C. M. Hustad, C. DaSilva, A. Santora and A. Ince

Bone, Vol.44, pp.S103-S104

2009

Metrics

5 Record Views

Title: Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density
Creators: J. A. Eisman (Author)
Robert R. Recker (Author) - Creighton University
M. McClung (Author)
H. Bone (Author)
C. Roux (Author)
N. Verbruggen (Author)
C. M. Hustad (Author)
C. DaSilva (Author)
A. Santora (Author)
A. Ince (Author)
Publication Details: Bone, Vol.44, pp.S103-S104
Number of pages: S103-S104
Identifiers: 991005932539702656
Academic Unit: School of Medicine; Endocrine
Resource Type: Journal article